Page last updated: 2024-08-18

quinuclidines and bromide

quinuclidines has been researched along with bromide in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Galley, P1
Yalcindag, ON1
Kissner, R; Koppenol, WH; Prütz, WA1
Cazzola, M; Matera, MG; Rinaldi, B; Rogliani, P1
Htet, A; Moe, S; Ni, H1
Birk, R; Farrell, C; Hayes, S; Lipson, DA; Mehta, R; Okour, M1
Fowler, A; Lee, LA; Peachey, G; Sule, N; Yang, S1
Bolotova, EV; Dudnikova, AV; Shulzhenko, LV1

Reviews

2 review(s) available for quinuclidines and bromide

ArticleYear
Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
    Expert review of clinical pharmacology, 2015, Volume: 8, Issue:1

    Topics: Benzyl Alcohols; Bromides; Bronchodilator Agents; Chlorobenzenes; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Randomized Controlled Trials as Topic

2015
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    The Cochrane database of systematic reviews, 2017, Jun-20, Volume: 6

    Topics: Anti-Bacterial Agents; Bromides; Disease Progression; Female; Forced Expiratory Volume; Hospitalization; Humans; Male; Middle Aged; Numbers Needed To Treat; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Smoking; Steroids

2017

Trials

2 trial(s) available for quinuclidines and bromide

ArticleYear
Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:1

    Topics: Administration, Inhalation; Aged; Androstadienes; Anticonvulsants; Benzyl Alcohols; Bromides; Chlorobenzenes; Drug Combinations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Quinuclidines

2020
Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN).
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:7

    Topics: Administration, Inhalation; Androstadienes; Asthma; Benzyl Alcohols; Bromides; Chlorobenzenes; Double-Blind Method; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Treatment Outcome

2021

Other Studies

4 other study(ies) available for quinuclidines and bromide

ArticleYear
[Value of a new combined antispasmodic-antalgic in current medical practice].
    Therapeutique (La Semaine des hopitaux), 1969, Volume: 45, Issue:10

    Topics: Analgesics; Benzilates; Bromides; Chlordiazepoxide; Drug Synergism; Gastrointestinal Diseases; Humans; Parasympatholytics; Quaternary Ammonium Compounds; Quinuclidines

1969
[Identification of benzilic acid esters].
    Die Pharmazie, 1970, Volume: 25, Issue:3

    Topics: Analgesics; Benzilates; Bromides; Colorimetry; Crystallography; Esters; Hallucinogens; Indicators and Reagents; Muscle Relaxants, Central; Parasympatholytics; Quinuclidines; Sulfuric Acids

1970
Oxidation of NADH by chloramines and chloramides and its activation by iodide and by tertiary amines.
    Archives of biochemistry and biophysics, 2001, Sep-15, Volume: 393, Issue:2

    Topics: Amines; Ammonium Chloride; Bromides; Catalysis; Chloramines; Halogens; Hydrogen-Ion Concentration; Hypochlorous Acid; Iodides; Kinetics; NAD; Oxidation-Reduction; Quinuclidines

2001
[Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease].
    Terapevticheskii arkhiv, 2022, Mar-15, Volume: 94, Issue:3

    Topics: Administration, Inhalation; Benzyl Alcohols; Bromides; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Humans; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinuclidines; Treatment Outcome

2022